| Product Code: ETC089507 | Publication Date: Jul 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Indonesia Antiparasitics Drugs Market was estimated at USD 379 Million in 2025 and is projected to reach USD 501 Million by 2032, growing at a CAGR of 4.1% from 2026 to 2032. This growth trajectory is significantly influenced by the rising incidence of parasitic infections in the region, particularly zoonotic diseases such as malaria and leishmaniasis. Additionally, heightened awareness of preventive measures and the availability of effective treatment options are further fueling market expansion.
This graph highlights how the Indonesia Antiparasitics Drugs Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -0.9% | Reduced domestic investments hampered antiparasitic production capacity expansion |
| 2022 | 4.4% | Accelerated local pharmaceutical production bolstered antiparasitic drug supply chains |
| 2023 | 5.6% | Domestic pharmaceutical manufacturers boost antiparasitic drug production capacity |
| 2024 | 5.3% | Pharmaceutical manufacturing upgrades boost antiparasitic drug production capacity |
| 2025 | 5.3% | OEM investments boosted capacity utilization in local antiparasitic production |
| 2026 | 5.3% | Domestic pharmaceutical production modernization enhances antiparasitic drug availability |
| 2027 | 4.9% | Digital health solutions boosted production efficiency in antiparasitic manufacturing |
| 2028 | 5.6% | Increased vehicle assembly demand boosted local API production capacity |
| 2029 | 5.5% | Manufacturing investments in local facilities boost antiparasitic drug production |
| 2030 | 5.4% | Regional pharmaceutical production ramp up drives antiparasitics demand recovery |
| 2031 | 5.4% | Pharmaceutical manufacturing capacity investments boosted antiparasitic drug output |
| 2032 | 5.5% | Modernized drug manufacturing facilities boost local antiparasitic production capacity |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The Indonesian landscape for antiparasitics is evolving, marked by a surge in public health initiatives aimed at combating infectious diseases. Recent years have seen a concerted effort from both governmental and private sectors to bolster healthcare infrastructure, directly impacting the availability and accessibility of antiparasitic treatments.
The growing awareness of the health impacts associated with parasitic infections is prompting greater investment in research and development. This translates to a more dynamic marketplace, where innovative products and robust distribution channels are becoming pivotal in reaching underserved populations.
Despite the positive growth outlook, the Indonesia Antiparasitics Drugs Market faces several constraints. Limited access to quality medications remains a significant challenge, particularly in remote areas where distribution can be erratic. Additionally, inadequate educational resources regarding proper drug usage can lead to improper treatment practices, resulting in a cycle of inefficiency in managing parasitic infections. Furthermore, the rising concern over antimicrobial resistance highlights the urgent need for new formulations and effective management strategies to combat evolving parasite strains.
Several key trends are shaping the landscape of the Indonesia Antiparasitics Drugs Market. The increase in zoonotic diseases, particularly malaria, is prompting a higher demand for effective treatment options. Concurrently, local pharmaceutical companies are innovating, reflecting a rising trend towards personalized medicine tailored for specific infections. Additionally, as the population becomes more health-conscious, there is a notable shift toward preventive healthcare measures, such as widespread vaccination programs and community health initiatives.
The opportunities within the Indonesia Antiparasitics Drugs Market are vast. The surge in healthcare spending opens doors for new entrants aiming to develop novel antiparasitic drugs. Additionally, the government's commitment to improving healthcare access creates an encouraging environment for investments in drug distribution and supply chain enhancement. The growing trend of telemedicine and digital health platforms also presents innovative channels to reach and educate patients, particularly in underserved regions.
The Indonesian government has been actively engaged in initiatives to strengthen public health concerning parasitic diseases. Increased funding for healthcare services has allowed for expanded vaccination programs and better access to essential medications. Public campaigns aimed at raising awareness about parasitic infections are also underway, promoting early diagnosis and treatment. By enhancing collaboration between public and private sectors, these initiatives aim to create a more resilient healthcare framework capable of addressing the challenges posed by infectious diseases.
Looking ahead to the period from 2026 to 2032, the Indonesia Antiparasitics Drugs Market is poised for considerable growth. The anticipated rise in healthcare expenditure combined with a focus on disease prevention will foster an environment conducive to innovation. With ongoing efforts to improve drug accessibility and enhance patient education, the market is expected to evolve significantly, driven by both domestic and international players seeking to address the pressing needs of the population.
Recent developments in the Indonesia Antiparasitics Drugs Market highlight a growing trend towards collaboration between research institutions and pharmaceutical companies. Notably, increased investments in local manufacturing facilities are aimed at reducing reliance on imports while enhancing the supply chain efficiency. Additionally, health organizations are expanding their roles in public education campaigns, emphasizing the importance of parasite screening and treatment adherence, thereby catalyzing a cultural shift towards proactive health management.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Antiparasitics Drugs Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Antiparasitics Drugs Market Revenues & Volume, 2022 & 2032F |
3.3 Indonesia Antiparasitics Drugs Market - Industry Life Cycle |
3.4 Indonesia Antiparasitics Drugs Market - Porter's Five Forces |
3.5 Indonesia Antiparasitics Drugs Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.6 Indonesia Antiparasitics Drugs Market Revenues & Volume Share, By Drug class, 2022 & 2032F |
3.7 Indonesia Antiparasitics Drugs Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Indonesia Antiparasitics Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of parasitic infections in Indonesia |
4.2.2 Growing awareness about the importance of parasite prevention and treatment |
4.2.3 Rise in disposable income leading to increased spending on healthcare including antiparasitics drugs |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in remote areas of Indonesia |
4.3.2 Low awareness about the availability and benefits of antiparasitics drugs |
4.3.3 Presence of counterfeit or substandard antiparasitics drugs in the market |
5 Indonesia Antiparasitics Drugs Market Trends |
6 Indonesia Antiparasitics Drugs Market, By Types |
6.1 Indonesia Antiparasitics Drugs Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Route of Administration, 2022-2032F |
6.1.3 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Oral, 2022-2032F |
6.1.4 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Injectable, 2022-2032F |
6.1.5 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Topical, 2022-2032F |
6.2 Indonesia Antiparasitics Drugs Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Anthelmintics, 2022-2032F |
6.2.3 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Antiprotozoals, 2022-2032F |
6.2.4 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Others, 2022-2032F |
6.3 Indonesia Antiparasitics Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Hospital Pharmacies, 2022-2032F |
6.3.3 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Retail Pharmacies, 2022-2032F |
6.3.4 Indonesia Antiparasitics Drugs Market Revenues & Volume, By Online Pharmacies, 2022-2032F |
7 Indonesia Antiparasitics Drugs Market Import-Export Trade Statistics |
7.1 Indonesia Antiparasitics Drugs Market Export to Major Countries |
7.2 Indonesia Antiparasitics Drugs Market Imports from Major Countries |
8 Indonesia Antiparasitics Drugs Market Key Performance Indicators |
8.1 Number of health education campaigns conducted on parasitic infections and treatment options |
8.2 Percentage increase in the number of healthcare facilities offering antiparasitics drugs |
8.3 Proportion of the population receiving regular preventive treatment for parasitic infections |
8.4 Rate of reported cases of parasitic infections in Indonesia |
8.5 Percentage of healthcare professionals trained in the diagnosis and treatment of parasitic infections |
9 Indonesia Antiparasitics Drugs Market - Opportunity Assessment |
9.1 Indonesia Antiparasitics Drugs Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.2 Indonesia Antiparasitics Drugs Market Opportunity Assessment, By Drug class, 2022 & 2032F |
9.3 Indonesia Antiparasitics Drugs Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Indonesia Antiparasitics Drugs Market - Competitive Landscape |
10.1 Indonesia Antiparasitics Drugs Market Revenue Share, By Companies, 2025 |
10.2 Indonesia Antiparasitics Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here